Movement Alert｜HBM HOLDINGS-B Rises 5.2% in Regular Trading, Subsidiary Develops Worlds First Fully Human Heavy-Chain Antibody Language Model

Market Focus

Sep 18

On September 18, HBM HOLDINGS-B rose 5.2% in regular trading, trading at HKD 13.54 per share, with turnover of HKD 18.13 million, extending the prior session's gains.

On the news front, the company's wholly-owned subsidiary Nona Biotech recently announced the successful development of HCAbLM — the world's first language model trained on fully human heavy-chain-only antibodies. Research results indicate that HCAbLM has learned unique sequence grammar associated with heavy-chain-only antibody formats, revealing sequence patterns and interrelationships that traditional antibody language models fail to adequately capture. The company stated that HCAbLM marks a significant milestone in applying artificial intelligence to antibody discovery and development. Industry observers noted this advancement not only demonstrates the company's leadership in antibody technology but also opens new R&D pathways for the broader sector.

Additionally, the company's shares were officially included in the Hang Seng Composite Index and became eligible for Stock Connect trading from September 7, which the board believes will help broaden its shareholder base and enhance trading liquidity.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketf.com/news/1193647052"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1193647052\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1193647052?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-18 09:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1193647052","market":"hk","top_or_hot":-1,"title":"Movement Alert｜HBM HOLDINGS-B Rises 5.2% in Regular Trading, Subsidiary Develops Worlds First Fully Human Heavy-Chain Antibody Language Model","media":"Market Focus","content":"<p><p>On September 18, HBM HOLDINGS-B rose 5.2% in regular trading, trading at HKD 13.54 per share, with turnover of HKD 18.13 million, extending the prior session's gains.</p><p>On the news front, the company's wholly-owned subsidiary Nona Biotech recently announced the successful development of HCAbLM — the world's first language model trained on fully human heavy-chain-only antibodies. Research results indicate that HCAbLM has learned unique sequence grammar associated with heavy-chain-only antibody formats, revealing sequence patterns and interrelationships that traditional antibody language models fail to adequately capture. The company stated that HCAbLM marks a significant milestone in applying artificial intelligence to antibody discovery and development. Industry observers noted this advancement not only demonstrates the company's leadership in antibody technology but also opens new R&D pathways for the broader sector.</p><p>Additionally, the company's shares were officially included in the Hang Seng Composite Index and became eligible for Stock Connect trading from September 7, which the board believes will help broaden its shareholder base and enhance trading liquidity.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜HBM HOLDINGS-B Rises 5.2% in Regular Trading, Subsidiary Develops Worlds First Fully Human Heavy-Chain Antibody Language Model</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜HBM HOLDINGS-B Rises 5.2% in Regular Trading, Subsidiary Develops Worlds First Fully Human Heavy-Chain Antibody Language Model\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-09-18 09:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On September 18, HBM HOLDINGS-B rose 5.2% in regular trading, trading at HKD 13.54 per share, with turnover of HKD 18.13 million, extending the prior session's gains.</p><p>On the news front, the company's wholly-owned subsidiary Nona Biotech recently announced the successful development of HCAbLM — the world's first language model trained on fully human heavy-chain-only antibodies. Research results indicate that HCAbLM has learned unique sequence grammar associated with heavy-chain-only antibody formats, revealing sequence patterns and interrelationships that traditional antibody language models fail to adequately capture. The company stated that HCAbLM marks a significant milestone in applying artificial intelligence to antibody discovery and development. Industry observers noted this advancement not only demonstrates the company's leadership in antibody technology but also opens new R&D pathways for the broader sector.</p><p>Additionally, the company's shares were officially included in the Hang Seng Composite Index and became eligible for Stock Connect trading from September 7, which the board believes will help broaden its shareholder base and enhance trading liquidity.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02142","symbol_name":"和铂医药-B","start_time":0,"source_url":"","article_id":"1193647052","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1193647052","pubTimestamp":1789695445,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On September 18, HBM HOLDINGS-B rose 5.2% in regular trading, trading at HKD 13.54 per share, with turnover of HKD 18.13 million, extending the prior session's gains.On the news front, the company's...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02142":"和铂医药-B"},"translate_title":"走势提醒|HBM HOLDINGS-B常规交易涨5.2%，子公司开发全球首个全人重链抗体语言模型","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02142":1},"content_text":"On September 18, HBM HOLDINGS-B rose 5.2% in regular trading, trading at HKD 13.54 per share, with turnover of HKD 18.13 million, extending the prior session's gains.On the news front, the company's wholly-owned subsidiary Nona Biotech recently announced the successful development of HCAbLM — the world's first language model trained on fully human heavy-chain-only antibodies. Research results indicate that HCAbLM has learned unique sequence grammar associated with heavy-chain-only antibody formats, revealing sequence patterns and interrelationships that traditional antibody language models fail to adequately capture. The company stated that HCAbLM marks a significant milestone in applying artificial intelligence to antibody discovery and development. Industry observers noted this advancement not only demonstrates the company's leadership in antibody technology but also opens new R&D pathways for the broader sector.Additionally, the company's shares were officially included in the Hang Seng Composite Index and became eligible for Stock Connect trading from September 7, which the board believes will help broaden its shareholder base and enhance trading liquidity.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}